FERRI, Clodoveo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 49.970
EU - Europa 25.010
AS - Asia 17.086
SA - Sud America 2.108
AF - Africa 249
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 39
Totale 94.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 49.532
GB - Regno Unito 9.892
IT - Italia 6.549
CN - Cina 5.871
SG - Singapore 4.778
HK - Hong Kong 2.737
SE - Svezia 1.968
BR - Brasile 1.714
DE - Germania 1.482
UA - Ucraina 1.397
TR - Turchia 1.336
RU - Federazione Russa 817
FR - Francia 769
FI - Finlandia 767
VN - Vietnam 625
BG - Bulgaria 496
KR - Corea 466
IN - India 352
ID - Indonesia 237
CA - Canada 197
IE - Irlanda 197
NL - Olanda 189
AR - Argentina 157
JP - Giappone 151
MX - Messico 132
ZA - Sudafrica 118
PL - Polonia 84
BD - Bangladesh 72
ES - Italia 69
IR - Iran 67
BZ - Belize 66
EC - Ecuador 65
BE - Belgio 58
AE - Emirati Arabi Uniti 52
MY - Malesia 52
IQ - Iraq 50
CL - Cile 42
AT - Austria 41
RO - Romania 41
LT - Lituania 39
CO - Colombia 36
EU - Europa 34
AU - Australia 31
MA - Marocco 31
PK - Pakistan 31
SA - Arabia Saudita 28
UZ - Uzbekistan 27
CH - Svizzera 26
PY - Paraguay 26
VE - Venezuela 25
EG - Egitto 21
KE - Kenya 19
PE - Perù 19
IL - Israele 18
TW - Taiwan 18
CZ - Repubblica Ceca 17
TN - Tunisia 16
JO - Giordania 15
NP - Nepal 15
AZ - Azerbaigian 14
PT - Portogallo 14
TH - Thailandia 14
KG - Kirghizistan 12
PH - Filippine 12
UY - Uruguay 12
BO - Bolivia 11
HU - Ungheria 11
LV - Lettonia 11
NO - Norvegia 10
DO - Repubblica Dominicana 9
GR - Grecia 9
AL - Albania 8
BY - Bielorussia 8
LU - Lussemburgo 8
OM - Oman 8
TT - Trinidad e Tobago 8
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
CI - Costa d'Avorio 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
MD - Moldavia 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
JM - Giamaica 4
PA - Panama 4
RS - Serbia 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CR - Costa Rica 3
GH - Ghana 3
GT - Guatemala 3
MK - Macedonia 3
NI - Nicaragua 3
SI - Slovenia 3
BH - Bahrain 2
BW - Botswana 2
Totale 94.450
Salva come PNG Salva come JPEG
Città #
Southend 7.726
Fairfield 5.007
Santa Clara 3.983
Woodbridge 3.480
Ashburn 3.084
Singapore 3.068
Jacksonville 2.761
Hong Kong 2.729
Houston 2.667
Chandler 2.065
Hefei 1.956
Ann Arbor 1.930
Seattle 1.794
Wilmington 1.786
Chicago 1.688
Dearborn 1.674
Cambridge 1.605
Los Angeles 1.316
London 1.157
Nyköping 1.083
Beijing 934
Izmir 824
Salt Lake City 746
Modena 621
San Diego 524
Princeton 523
Sofia 490
Milan 481
Eugene 448
The Dalles 445
New York 437
Rome 419
Seoul 419
Tampa 365
Elk Grove Village 328
Helsinki 319
Buffalo 279
Council Bluffs 272
Dallas 264
Des Moines 247
Moscow 244
Columbus 243
Shanghai 218
Ho Chi Minh City 205
Atlanta 193
Jakarta 192
Redwood City 179
Bremen 169
Dublin 168
Sterling 160
São Paulo 154
Hanoi 150
Lancaster 149
San Jose 129
Frankfurt am Main 123
Bologna 122
Guangzhou 121
Boardman 110
Florence 110
Norwalk 110
Dulles 100
Miami 99
Naples 95
Falls Church 94
Phoenix 93
Palermo 92
Tokyo 92
Detroit 90
Delhi 84
Turin 81
New Delhi 73
Munich 71
Nanjing 70
Genoa 68
Bari 67
Kansas City 67
Verona 67
Belize City 66
Catania 65
Warsaw 61
Toronto 58
Denver 57
Dong Ket 56
Jinan 56
Brooklyn 53
Kunming 53
Montreal 53
Padova 51
Pittsburgh 51
Brussels 50
Johannesburg 50
Redondo Beach 49
Belo Horizonte 47
Mexico City 47
Zhengzhou 46
Hounslow 44
San Francisco 41
Cagliari 40
Wuhan 40
Rio de Janeiro 39
Totale 67.769
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.706
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 863
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 737
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 728
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 501
Semeiotica dell'articolazione temporo-mandibolare 486
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 408
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 402
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 396
B-cells and mixed cryoglobulinemia 394
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 386
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 380
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 369
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 354
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 353
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 348
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 345
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 341
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 336
Endocrine manifestations of hepatitis C virus infection. 335
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 334
Thymus alterations and systemic sclerosis 333
Validation of the classification criteria for cryoglobulinaemic vasculitis 332
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 330
Heart involvement and systemic sclerosis 328
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 327
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 325
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 325
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 323
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 322
Scleroderma digital ulcers complicated by infection with fecal pathogens. 318
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 318
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 316
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 313
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 310
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 308
Current treatment of hepatitis C-associated rheumatic diseases. 307
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 306
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 303
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 301
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 300
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 300
Aortic pulse wave velocity measurement in systemic sclerosis patients. 300
L-Arginine in pregnant scleroderma patients 299
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 298
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 296
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 294
The A, B, Cs of viral hepatitis in the biologic era. 293
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 292
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 291
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 290
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 290
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 289
Cardiac Involvement in Systemic Vasculitis 289
Elevated Troponin Serum Levels in Adult Onset Still's Disease 287
Non HCV-related mixed cryoglobulinemia 284
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 282
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 282
Platelet gel in the treatment of severe scleroderma skin ulcers. 281
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 280
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 280
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 278
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 277
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 277
HCV and cryoglobulinemic vasculitis. 276
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 276
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 276
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 275
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 275
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 273
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 272
Role of the HLA class II: HCV-related disorders 272
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 271
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 271
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 270
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 268
GISEA: an Italian biological agents registry in rheumatology 266
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 266
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 266
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. 263
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection. 263
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 262
Cytokines and HCV-related disorders 261
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 261
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 261
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 260
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 257
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 257
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 256
Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. 255
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 255
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 254
Incidence and characteristics of non-hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias 254
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 254
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 253
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 252
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 252
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 252
Cardiovascular risk and prostanoids in systemic sclerosis 250
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 250
Totale 34.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 392.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 392.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.257 0 0 0 0 0 939 959 1.702 405 1.070 658 524
2021/20227.902 212 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/202516.486 663 224 296 1.315 3.092 2.336 829 931 1.887 1.376 1.659 1.878
2025/202618.444 1.673 1.206 2.549 4.695 7.278 1.043 0 0 0 0 0 0
Totale 95.245